AGILE THERAPEUTICS INC

🇺🇸United States
Ownership
-
Employees
-
Market Cap
$10.4M
Website
Clinical Trials
Related News

Efficacy, Safety and Tolerability Study of Agile AG200-15 Transdermal Contraceptive Delivery System

Phase 3
Completed
Conditions
Healthy
Interventions
Drug: AG200-15
First Posted Date
2014-06-09
Last Posted Date
2020-05-06
Lead Sponsor
Agile Therapeutics
Target Recruit Count
2032
Registration Number
NCT02158572

Study to Evaluate Pharmacokinetics Profile, Wearability, and Safety of 2 Progestin-Only Patches

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: levonorgestrel
First Posted Date
2012-06-20
Last Posted Date
2018-01-23
Lead Sponsor
Agile Therapeutics
Target Recruit Count
36
Registration Number
NCT01623466

Pharmacokinetic Study of AG200-15 Transdermal Patch to Three Anatomical Sites in Healthy Females

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: AG200-15
First Posted Date
2011-08-23
Last Posted Date
2018-12-31
Lead Sponsor
Agile Therapeutics
Target Recruit Count
24
Registration Number
NCT01422135

Pharmacokinetic Study Of AGILE AG200-15 After Weekly Application Under Various Conditions in Healthy Female Volunteers

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: AG200-15
First Posted Date
2011-06-20
Last Posted Date
2018-07-31
Lead Sponsor
Agile Therapeutics
Target Recruit Count
24
Registration Number
NCT01375946
Locations
🇺🇸

Clinical Pharmacology of Miami, Inc., Miami, Florida, United States

Evaluation of Pharmacodynamic Effects on Ovulation and Cycle Control

First Posted Date
2010-11-30
Last Posted Date
2018-07-05
Lead Sponsor
Agile Therapeutics
Target Recruit Count
123
Registration Number
NCT01250210

AG200-15 Transdermal Contraceptive Delivery System (TCDS) of Levonorgestrel and Ethinyl Estradiol

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Ortho-Cyclen
Drug: AG200-15
First Posted Date
2010-11-18
Last Posted Date
2018-01-23
Lead Sponsor
Agile Therapeutics
Target Recruit Count
36
Registration Number
NCT01243580

Transdermal Contraceptive Delivery System (TCDS), Also Known as AG200-15 Patch Arm

Phase 3
Completed
Conditions
Contraception
Interventions
Drug: AG200-15
Drug: Levora
First Posted Date
2010-11-09
Last Posted Date
2017-09-15
Lead Sponsor
Agile Therapeutics
Target Recruit Count
407
Registration Number
NCT01236768

Study to Evaluate the Contraceptive Efficacy/Safety of a Low Dose EE/LNG Transdermal Contraceptive Delivery System

First Posted Date
2010-08-13
Last Posted Date
2018-07-03
Lead Sponsor
Agile Therapeutics
Target Recruit Count
1504
Registration Number
NCT01181479
Locations
🇺🇸

Agile Investigational Site, Seattle, Washington, United States

🇺🇸

Agile Investigational, Sacramento, California, United States

© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy